The standard treatment for chronic phase CML is a tyrosine kinase inhibitor (TKI) likeimatinib (Gleevec), nilotinib (Tasigna), dasatinib (Sprycel), or bosutinib (Bosulif). If the first drug stops working or it never really worked well at all, the dose may be increased or another TKI might ...